Atul Mukund Deshpande
Plus aucun poste en cours
Profil
Atul Mukund Deshpande worked as an Associate Director at Sanofi, Inc. (China) from 2012 to 2014 and as an Executive Director & Chief Strategy Officer at HBM Holdings Ltd.
from 2018 to 2021.
He earned a doctorate degree from the University of California, Irvine in 2007, an MBA from Cranfield University in 2011, and an undergraduate degree from the University of Mumbai in 2000.
Anciens postes connus de Atul Mukund Deshpande
| Sociétés | Poste | Fin |
|---|---|---|
| HBM HOLDINGS LIMITED | Directeur/Membre du Conseil | 25/04/2021 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Corporate Officer/Principal | 01/12/2014 |
Formation de Atul Mukund Deshpande
| University of Mumbai | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Health Technology |
